Bio-Rad Laboratories（紐約證券交易所代碼：BIO）報告季度每股收益為 $2.90，高於分析師一致預期的 $2.86，增幅為 1.4%。 與去年同期的每股收益 $3.10 相比，下降了 6.45%。公司報告季度銷售額為 $6.675億，低於分析師一致預期的 $6.793億，減少了 1.74%。 與去年同期的銷售額 $6.8118億 相比，減少了 2.01%。
以上內容來自Benzinga Earnings專欄，原文如下：
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.90 per share which beat the analyst consensus estimate of $2.86 by 1.4 percent. This is a 6.45 percent decrease over earnings of $3.10 per share from the same period last year. The company reported quarterly sales of $667.50 million which missed the analyst consensus estimate of $679.30 million by 1.74 percent. This is a 2.01 percent decrease over sales of $681.18 million the same period last year.